UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation
CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly. The dual-payload antibody-drug conjugate technology was originally created by…
From monsters to medicine: Graduate turns childhood fantasies into cancer-fighting reality
Growing up in a log cabin in the forests of upstate New York, Kendra Carmon, PhD ‘08, was captivated by black-and-white horror movies of mad scientists mixing chemicals and creating monsters in their laboratories. “I thought it would be super…
Momeny receives NETRF grant
The Neuroendocrine Tumor Research Foundation (external link) has announced Majid Momeny, PhD, instructor at the Brown Foundation Institute of Molecular Medicine Center for Translational Cancer Research as a recipient of its newest neuroendocrine cancer research grants. “I am grateful to…